US Patent & Trademark Office Rejects Symantec Corp.'s Efforts to Invalidate Two Finjan Patents

On February 26, the United States Patent & Trademark Office rejected Symantec Corporations’ efforts to invalidate two of Finjan Holdings, Inc. (NASDAQ:FNJN) subsidiary Finjan, Inc.’s patents.
According to the press release:

Symantec’s petitions (Cases IPR2015-01895 and IPR2015-01897) allege that Finjan’s patents, U.S. Patent Nos. 7,613,926 (“the ‘926 Patent”) and 8,677,494 (“the ‘494 Patent”) are invalid. The PTAB determined that Symantec failed to establish a reasonable likelihood that it would prevail at trial in showing either the ‘926 or the ‘494 Patents are invalid.
Relatedly, on February 25, 2016, the PTAB also denied all three of Symantec’s Request for Rehearing on the PTAB’s earlier denials of Symantec’s petitions for IPRs, directed to Finjan’s US Patent Nos. 7,756,996 (IPR2015-01545/-01546) and 8,141,154 (IPR2015-01547).
“There can be no doubt that Symantec’s last two failed attempts to institute trial by the PTAB further strengthen not only Finjan’s ‘926 and ‘494 Patents but also its portfolio of core cybersecurity patents as a whole,” said Julie Mar-Spinola, Finjan Holdings’ CIPO and VP, Legal. “Our string of wins against numerous challenges to our patents in the courts and before the PTAB reinforces our determination to seek fair and just value for our patents from those we believe are practicing our patented innovations without a license.”

Click here to view the full press release.